Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevuparin as Adjunctive Therapy in Uncomplicated Falciparum Malaria
NCT01442168Phase 2Terminated
- Sponsor
- Modus Therapeutics
- Start
- Sep 2011
- Primary completion
- Sep 2013
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sevuparin in Malaria, sponsored by Modus Therapeutics. Started Sep 2011; status: terminated.
02
Drugs
sevuparin
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT01442168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01442168.